Lunai Bioworks Inc. (LNAI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 20.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 11K | 11.33K | 41.52K | 32.63K | 0 | 0 | 0 | 0 | 30.3K | 33.16K |
| COGS % of Revenue | 52.53% | - | - | - | - | - | - | - | - | - |
| Gross Profit | 9.94K | -11.33K | -41.52K | -32.63K | 0 | 0 | 0 | 0 | -30.3K | -33.16K |
| Gross Margin % | 47.47% | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 100% | 100% | - | - | - | - |
| Operating Expenses | 1.44M | 1.81M | 2.43M | 4.08M | 4.16M | 4.55M | 53.34M | 51.29M | 8.74M | 4.24M |
| OpEx % of Revenue | 6862.77% | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.42M | 1.77M | 2.41M | 4M | 4.22M | 4.35M | 5.3M | 5M | 7.65M | 3.62M |
| SG&A % of Revenue | 6786.62% | - | - | - | - | - | - | - | - | - |
| Research & Development | 15.95K | 45.87K | 24.41K | 80.23K | -94.07K | 161.08K | 390.19K | 434.51K | 1.09M | 620.52K |
| R&D % of Revenue | 76.14% | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 31.98K | 32.11K | 1000K | 1000K | 0 | 0 |
| Operating Income | -1.43M | -1.82M | -2.48M | -4.11M | -4.16M | -4.55M | -53.34M | -51.29M | -8.77M | -4.27M |
| Operating Margin % | -6815.3% | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 65.71% | 59.89% | 95.36% | 91.98% | 52.54% | -6.47% | - | - | - | - |
| EBITDA | -1.42M | -1.81M | -2.43M | -4.08M | -4.13M | -4.51M | -53.31M | -51.26M | -8.74M | -4.24M |
| EBITDA Margin % | -6762.77% | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 65.71% | 59.86% | 95.43% | 92.04% | 52.74% | -6.54% | - | - | - | - |
| D&A (Non-Cash Add-back) | 11K | 11.33K | 41.52K | 32.63K | 31.98K | 32.11K | 32.38K | 31.13K | 30.3K | 33.16K |
| EBIT | -2.46M | -1.68M | 3.01M | -126.54M | 377.86K | -7.14M | -43.96M | -48.24M | -58.69M | -4.25M |
| Net Interest Income | -108.05K | -121.51K | -188.61K | -181.16K | -188.61K | -116.08K | -123.48K | -1.68M | -303.8K | -274.98K |
| Interest Income | 0 | 0 | 72 | 6.86K | 72 | 0 | 126.6K | 0 | 0 | 0 |
| Interest Expense | 108.05K | 121.51K | 188.69K | 188.03K | 188.69K | 116.08K | 250.08K | 1.68M | 303.8K | 274.98K |
| Other Income/Expense | -1.14M | 24.01K | 5.3M | -122.62M | 4.35M | -2.71M | 9.13M | 1.37M | -50.22M | -259.05K |
| Pretax Income | -2.57M | -1.8M | 2.82M | -126.73M | 189.18K | -7.25M | -44.21M | -49.92M | -58.99M | -4.53M |
| Pretax Margin % | -12278.65% | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.57M | -1.8M | 2.82M | -126.73M | 189.18K | -7.25M | -44.21M | -49.92M | -58.99M | -4.53M |
| Net Margin % | -12278.65% | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -1459.26% | 75.19% | 106.38% | -153.86% | 100.32% | -60.13% | - | - | - | - |
| Net Income (Continuing) | -2.57M | -1.8M | 2.82M | -126.73M | 189.18K | -7.25M | -44.21M | -49.92M | -58.99M | -4.53M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.80 | -0.61 | 1.04 | -60.88 | 0.09 | -3.20 | -22.40 | -31.04 | -43.20 | -5.52 |
| EPS Growth % | -969.57% | 80.85% | 104.64% | -96.13% | 100.21% | 42.03% | - | - | - | - |
| EPS (Basic) | -0.80 | -0.61 | 1.04 | -60.88 | 0.09 | -3.20 | -22.40 | -31.04 | -43.20 | -5.52 |
| Diluted Shares Outstanding | 3.12M | 2.94M | 2.82M | 2.08M | 2.05M | 2.02M | 2M | 1.61M | 1.37M | 823.16K |
| Basic Shares Outstanding | 3.12M | 2.94M | 2.82M | 2.08M | 2.03M | 2.02M | 2M | 1.61M | 1.37M | 823.16K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |